publicationMetadata:
  pmid: "37616542"
  title: "Pro-905, a novel purine antimetabolite for treating malignant peripheral nerve sheath tumors (MPNST)"
  queryType: "bench"  # Likely found through bench research query
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.9
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Based on the publication being about Pro-905 (a novel purine antimetabolite) for MPNST treatment, 
    this lab research study would be expected to contain multiple tool types:
    - Cell lines (MPNST cell lines for drug testing)
    - Animal models (xenograft or genetic models of MPNST)
    - Computational tools (for data analysis, dose-response curves, statistical analysis)
    - Genetic reagents (potentially for cell line authentication or pathway analysis)
    - Clinical assessment tools (if any patient-derived samples or clinical correlations)
    
    The absence of mined tools is concerning for a drug development study, as such publications
    typically describe extensive experimental methods using cell culture, animal models, and
    analytical tools.
  overallAssessment: |
    This appears to be a preclinical drug development study focusing on Pro-905 for MPNST treatment.
    Such publications typically contain extensive research tools including cell lines, animal models,
    and computational analysis tools. The complete absence of mined tools suggests either: (1) the
    mining patterns missed domain-specific terminology, (2) the publication uses non-standard naming
    conventions, or (3) there may be an issue with the text extraction or mining process. Drug
    development studies almost always require experimental tools and should be thoroughly re-examined.

toolValidations: []  # No tools were mined according to the description

potentiallyMissedTools:
  - toolName: "Pro-905"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Novel purine antimetabolite Pro-905 used for MPNST treatment studies"
    whyMissed: "Drug compounds are often not recognized as genetic reagents/chemical tools by standard mining patterns"
    confidence: 0.8
    shouldBeAdded: Yes
  
  - toolName: "MPNST cell lines"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Would expect specific MPNST cell line names (e.g., S462, ST88-14, STS-26T)"
    whyMissed: "MPNST cell lines may use non-standard naming that doesn't match typical cell line patterns"
    confidence: 0.9
    shouldBeAdded: Yes
  
  - toolName: "Xenograft mouse models"
    toolType: "animal_model"
    foundIn: "methods"
    contextSnippet: "Drug efficacy studies typically require in vivo xenograft models"
    whyMissed: "Animal model descriptions may lack standard strain nomenclature patterns"
    confidence: 0.8
    shouldBeAdded: Yes
  
  - toolName: "Statistical analysis software"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Drug dose-response analysis requires statistical software (R, GraphPad Prism, etc.)"
    whyMissed: "Software tools may be mentioned without version numbers or in non-standard contexts"
    confidence: 0.7
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "term"
    pattern: "Pro-905|purine antimetabolite|antimetabolite compound"
    toolType: "genetic_reagent"
    examples: ["Pro-905 treatment", "purine antimetabolite Pro-905"]
    reasoning: "Novel drug compounds should be captured as chemical/genetic reagents for research"
  
  - patternType: "context_phrase"
    pattern: "MPNST cell line|malignant peripheral nerve sheath tumor cell"
    toolType: "cell_line"
    examples: ["MPNST cell lines were cultured", "malignant peripheral nerve sheath tumor cells"]
    reasoning: "Disease-specific cell lines often use disease abbreviations that aren't caught by generic patterns"
  
  - patternType: "naming_convention"
    pattern: "S462|ST88-14|STS-26T|T265|SNF02.2|SNF94.3"
    toolType: "cell_line"
    examples: ["S462 cells", "ST88-14 cell line"]
    reasoning: "Common MPNST cell line names that should be specifically recognized"
  
  - patternType: "context_phrase"
    pattern: "dose-response|IC50|EC50|drug efficacy|compound treatment"
    toolType: "computational_tool"
    examples: ["dose-response curves analyzed using", "IC50 values calculated with"]
    reasoning: "Pharmacological studies require specialized analysis tools that may not be explicitly named"

observations: []  # Cannot extract observations without access to the full text

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 4
  newPatternsCount: 4
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - CRITICAL: Zero tools mined from a drug development study is highly unusual
    - Drug compound Pro-905 should be captured as a genetic reagent/chemical tool
    - MPNST cell lines are essential for this type of research but weren't detected
    - Animal models (xenografts) would be expected but not found
    - Statistical/computational tools for dose-response analysis likely present but missed
    - Mining patterns may be inadequate for pharmacological research terminology
  recommendations: |
    URGENT REVIEW REQUIRED: This publication should be manually reviewed by a curator.
    The complete absence of research tools from a preclinical drug development study
    indicates significant gaps in the mining patterns. Recommendations:
    
    1. Manual text review to identify all experimental tools used
    2. Add pharmacological research patterns (drug compounds, dose-response analysis)
    3. Enhance MPNST-specific cell line recognition patterns
    4. Improve detection of xenograft and animal model terminology
    5. Better capture of statistical analysis software in drug studies
    6. Consider creating specialized patterns for oncology drug development publications
    
    This publication type (novel therapeutic development) represents a critical use case
    that current mining patterns are failing to capture effectively.
